QTRX: Quanterix EV/EBITDA Multiple

Corporate emblem and logo of Quanterix (QTRX)

Serving as a valuation tool, the EV/EBITDA chart for Quanterix Corporation (QTRX) on the GURU.Markets platform is fixed at 0.00. The business relies on a team of leading industry specialists and rare software developers with minimal staff turnover. Revenue is generated through the sale of high-precision analyzers and recurring reagent sales, ensuring a steady cash flow. An innovative approach to protein detection creates a foundation for the early identification of pathologies.

Quanterix Inc - QTRX Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/16/2026)

Summary analytical data breakdowns for Quanterix (QTRX)

- stock price and consensus target price:
Initial company analysis:Quanterix QTRX
Original product of quanterix.com

The EV/EBITDA multiple determines the value of a business relative to its operating profit before depreciation, taxes, and interest. The price action of the EV/EBITDA metric, which assesses debt and operating leverage, reflects the real market value of assets inclusive of all liabilities. This metric correlates total capitalization with cash flow, eliminating the influence of the debt structure. Stable test system sales for Quanterix Corporation (QTRX) ensure a predictable cash inflow, making this indicator key to analyzing the company's resilience.

Competitor analysis for Quanterix Corporation

EV/EBITDA Multiple ABT (abbott.com)|Total Company Value to Operating Income Before Depreciation Ratio Thermo Fisher Scientific (TMO)|GE HealthCare Technologies Inc. - EV/EBITDA Multiple|Mettler-Toledo International Inc. (MTD) - Enterprise Value to EBITDA Ratio|WAT (Waters Corp.) - Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Ratio Bio-Techne Corporation|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging Corp (VREX)|Enterprise Value to EBITDA Ratio Semler Scientific SMLR|EV/EBITDA Multiple BFLY (butterflynetwork.com)|Mesa Labs Corp (MLAB) - Company Value to EBITDA|quantum-si.com - EV/EBITDA Multiple|NNOX (Nano-X Imaging Ltd.) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CapsoVision Medical (CV) - EV/EBITDA Multiple|MXCT (MaxCyte Inc) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro Biosystems (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple hyperfine.io (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR FONR|Business Value to Operating Income Before Depreciation DXR|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings, Inc.)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization thermogenesis.com|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems Inc.)